Optimizing particle-mediated epidermal delivery of an influenza DNA vaccine in ferrets

Methods in Molecular Biology

Volumn 940, Issue , 2013, Pages 223-237

  Yager, Eric J ^a   Stagnar, Cristy ^b   Gopalakrishnan, Ragisha ^c   Fuller, James T ^d   Fuller, Deborah H ^d  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b WADSWORTH CENTER   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antibodies; DNA vaccine; Epidermis; Ferrets; Hemagglutinin; Influenza A virus; PMED

Indexed keywords

BETA GALACTOSIDASE; DNA VACCINE; HEPATITIS B CORE ANTIGEN; VIRUS VACCINE;

ANIMAL; ARTICLE; BIOLISTIC TRANSFORMATION; EPIDERMIS; FERRET; GENETICS; HEMAGGLUTINATION INHIBITION TEST; IMMUNIZATION; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INSTRUMENTATION; MALE; METABOLISM; REPORTER GENE;

ANIMALS; BETA-GALACTOSIDASE; BIOLISTICS; EPIDERMIS; FERRETS; GENES, REPORTER; HEMAGGLUTINATION INHIBITION TESTS; HEPATITIS B CORE ANTIGENS; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; MALE; VACCINES, DNA; VIRAL VACCINES;

ANIMALIA; INFLUENZA A VIRUS; MUSTELA; ORTHOMYXOVIRIDAE;

EID: 84870500534     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-110-3_19     Document Type: Article

References (28)

1. Fuller DH, Loudon P, Schmaljohn C (2006) Preclinical and clinical progress of particlemediated DNA vaccines for infectious diseases. Methods 40:86-97
2. Payne LG, Fuller DH, Haynes JR (2002) Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogma. Curr Opin Mol Ther 4:459-466
3. Yager EJ, Dean HJ, Fuller DH (2009) Prospects for developing an effective particle-mediated DNA vaccine against in fluenza. Expert Rev Vaccines 8:1205-1220
4. Falo LD Jr (1999) Targeting the skin for genetic immunization. Proc Assoc Am Physicians 111:211-219
5. Falo LD Jr, Storkus WJ (1998) Giving DNA vaccines a helping hand. Nat Med 4: 1239-1240
6. Bennett AM et al (1999) Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus. Vaccine 18:588-596
7. Huber VC, Thomas PG, McCullers JA (2009) A multI-valent vaccine approach that elicits broad immunity within an in fluenza subtype. Vaccine 27:1192-1200
8. Pertmer TM et al (1995) Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13: 1427-1430
9. Roberts LK et al (2005) Clinical safety and ef ficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. Vaccine 23: 4867-4878
10. Drape RJ et al (2006) Epidermal DNA vaccine for in fluenza is immunogenic in humans. Vaccine 24:4475-4481
11. Jones S et al (2009) DNA vaccination protects against an in fluenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial. Vaccine 27:2506-2512
12. Fuller DH et al (1997) Enhancement of immunode ficiency virus-speci fic immune responses in DNA-immunized rhesus macaques. Vaccine 15:924-926
13. Fuller DH et al (2002) Induction of mucosal protection against primary, heterologous simian immunode ficiency virus by a DNA vaccine. J Virol 76:3309-3317
14. Fuller DH et al (2006) DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued. Virology 348:200-215
15. Doria-Rose NA et al (2003) Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simianhuman immunode ficiency virus SHIV89.6P mucosal challenge. J Virol 77:11563-11577
16. Eisenbraun MD, Fuller DH, Haynes JR (1993) Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol 12:791-797
17. Fynan EF, Robinson HL, Webster RG (1993) Use of DNA encoding in fluenza hemagglutinin as an avian in fluenza vaccine. DNA Cell Biol 12:785-789
18. Macklin MD et al (1998) Immunization of pigs with a particle-mediated DNA vaccine to in fluenza A virus protects against challenge with homologous virus. J Virol 72:1491-1496
19. Marini RP et al (2002) Biology and diseases of ferrets. In: Fox JG, Anderson LC, Loew FM, Quimby FW (eds) Laboratory animal medicine. Academic, San Diego, pp 483-517
20. Maher JA, DeStefano J (2004) The ferret: an animal model to study in fluenza virus. Lab Anim (NY) 33:50-53
21. Matsuoka Y, Lamirande EW, Subbarao K (2009) The ferret model for in fluenza. Curr Protoc Microbiol Chapter 15:Unit 15G 12
22. Loudon PT et al (2010) GM-CSF increases mucosal and systemic immunogenicity of an H1N1 in fluenza DNA vaccine administered into the epidermis of non-human primates. PLoS One 5:e11021
23. Roy MJ et al (2000) Induction of antigenspeci fic CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19:764-778
24. Wang S, Joshi S, Lu S (2004) Delivery of DNA to skin by particle bombardment. Methods Mol Biol 245:185-196
25. Couch RB, Kasel JA (1983) Immunity to in fluenza in man. Annu Rev Microbiol 37: 529-549
26. Kildsgaard J et al (2007) Sublingual immunotherapy in sensitized mice. Ann Allergy Asthma Immunol 98:366-372
27. Song JH et al (2008) Sublingual vaccination with in fluenza virus protects mice against lethal viral infection. Proc Natl Acad Sci USA 105:1644-1649
28. Cuburu N et al (2007) Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 25: 8598-8610